Analogic (NASDAQ:ALOG) was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Saturday.
Several other research firms have also recently commented on ALOG. Zacks Investment Research cut Analogic from a “buy” rating to a “hold” rating in a research report on Tuesday, November 21st. Jefferies Group restated a “hold” rating and set a $80.00 target price on shares of Analogic in a research report on Friday, December 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $88.33.
Analogic (NASDAQ ALOG) traded up $0.65 during trading hours on Friday, hitting $84.30. The company had a trading volume of 31,216 shares, compared to its average volume of 78,913. Analogic has a 12 month low of $66.00 and a 12 month high of $89.50. The company has a market cap of $1,060.00, a price-to-earnings ratio of -14.76, a price-to-earnings-growth ratio of 4.18 and a beta of 0.86.
Institutional investors and hedge funds have recently bought and sold shares of the company. Citadel Advisors LLC boosted its holdings in shares of Analogic by 88.8% in the 2nd quarter. Citadel Advisors LLC now owns 128,879 shares of the medical research company’s stock worth $9,363,000 after purchasing an additional 60,614 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Analogic by 3.1% in the 2nd quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock worth $83,359,000 after purchasing an additional 34,765 shares in the last quarter. SG Americas Securities LLC boosted its holdings in shares of Analogic by 470.7% in the 2nd quarter. SG Americas Securities LLC now owns 7,619 shares of the medical research company’s stock worth $554,000 after purchasing an additional 6,284 shares in the last quarter. TIAA CREF Investment Management LLC boosted its holdings in shares of Analogic by 33.1% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 56,358 shares of the medical research company’s stock worth $4,094,000 after purchasing an additional 14,022 shares in the last quarter. Finally, Koch Industries Inc. boosted its holdings in shares of Analogic by 8,505.7% in the 2nd quarter. Koch Industries Inc. now owns 321,335 shares of the medical research company’s stock worth $317,000 after purchasing an additional 317,601 shares in the last quarter. Hedge funds and other institutional investors own 97.68% of the company’s stock.
TRADEMARK VIOLATION WARNING: This news story was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2018/01/06/analogic-alog-downgraded-to-strong-sell-at-bidaskclub.html.
Analogic Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.